Literature DB >> 6802034

The effect of acute phencyclidine administration on cyclopropane requirement (MAC) in rats.

S N Raja, J C Moscicki, J R Woodside, C A DiFazio.   

Abstract

The effect of acute administration of phencyclidine (PCP) on the anesthetic requirement (MAC) was studied in rats. Rats were anesthetized with cyclopropane and MAC determinations were made by the tail-clamp technique. PCP, 2 or 4 mg/kg, subcutaneously, produced a 32 and 42 per cent decrease, respectively, in cyclopropane MAC. The PCP-induced decrease in MAC was not altered by naloxone treatment indicating that an interaction of PCP with opiate mechanisms is unlikely. Central monoamine depletion with reserpine decreased cyclopropane MAC by 20 per cent. In these monoamine-depleted rats, 4 mg/kg PCP produced a further reduction in MAC of 22 per cent. In rats almost totally depleted of catecholamines by pretreatment with reserpine and alpha-methyl-p-tyrosine, a marked (43 per cent) decrease in MAC was observed. The administration of 2 mg/kg PCP, in these catecholamine-depleted rats produced an additional 10 per cent decrease in MAC for a total reduction in MAC of 53 per cent. The effect of PCP in the monoamine- and catecholamine-depleted rats indicates that while an effect on central monoamines may play a part in the mechanism of action of PCP, it is not the sole mode of action of the drug. In patients intoxicated with PCP there is a significant potential for anesthetic overdose as their anesthetic requirement may be much less than would be expected in the nonintoxicated state.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802034     DOI: 10.1097/00000542-198204000-00008

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  3 in total

Review 1.  Using EEG to monitor anesthesia drug effects during surgery.

Authors:  Leslie C Jameson; Tod B Sloan
Journal:  J Clin Monit Comput       Date:  2006-12       Impact factor: 2.502

2.  Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer.

Authors:  Yat Hang To; Koen Degeling; Suzanne Kosmider; Rachel Wong; Margaret Lee; Catherine Dunn; Grace Gard; Azim Jalali; Vanessa Wong; Maarten IJzerman; Peter Gibbs; Jeanne Tie
Journal:  Pharmacoeconomics       Date:  2021-06-05       Impact factor: 4.981

Review 3.  Is a new paradigm needed to explain how inhaled anesthetics produce immobility?

Authors:  Edmond I Eger; Douglas E Raines; Steven L Shafer; Hugh C Hemmings; James M Sonner
Journal:  Anesth Analg       Date:  2008-09       Impact factor: 5.108

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.